Trial Profile
The Safety and Immunogenicity of Enterovirus Type 71 Inactivated Vaccine (Human Diploid Cell) With Two Measles Attenuated Live Vaccine and Live Attenuated Japanese Encephalitis Vaccine at the Same Time Point in Infants (8-month-old)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Pharmacodynamics
- 23 Jun 2022 Results assessing immunogenicity and safety of simultaneous administration of the enterovirus 71 (EV71) vaccine with the measles and rubella (MR) combined vaccine published in the Vaccine
- 05 Oct 2017 New trial record